BULLETIN: Banco Bilbao Vizcaya Argentaria Ratings Unchanged On News Of U.S. Purchases Jun 06

  • ID: 1869736
  • June 2006
  • Region: United States
  • Standard & Poors
1 of 3

MADRID (Standard & Poor's) June 13, 2006--Standard & Poor's Ratings Services said today that its ratings and outlook on Banco Bilbao Vizcaya Argentaria, S.A. (BBVA, AA-/Stable/A-1+) remain unchanged following the Spanish bank's announcement of its acquisition of U.S. banks Texas Regional Bancshares and State National Bancshares. These two acquisitions fit well with BBVA's stated strategy of expanding its presence around the U.S.-Mexico border. We expect BBVA to be cautious in its U.S. expansion, in order to overcome the difficulties of extending its franchise in the highly competitive, sophisticated U.S. market and to minimize the potential problems of rapid growth in the region. BBVA will finance the acquisitions with the expected gains from the sale of its stakes in Banca Nazionale...

Companies mentioned in this report are:
- Banco Bilbao Vizcaya Argentaria S.A.

Action: Bulletin

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Banco Bilbao Vizcaya Argentaria S.A.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown





Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.